Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer: a population-based register study

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: onr:"swepub:oai:DiVA.org:umu-228044" > Fluid therapy is as...

1 av 1
Föregående post
Nästa post
Till träfflistan

Lindskog, MagnusDepartment of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Solna, Sweden; Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden (författare)

Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer : a population-based register study

Artikel/kapitelEngelska2024

Förlag, utgivningsår, omfång ...

BioMed Central (BMC),2024
electronicrdacarrier

Nummerbeteckningar

LIBRIS-ID:oai:DiVA.org:umu-228044
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-228044URI
https://doi.org/10.1186/s12904-024-01504-5DOI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

Background: Parenteral fluid (PF) therapy of patients in end-of-life (EOL) is controversial. The purpose of this study was to assess associations between PF, quality of the EOL care process and symptom burden in dying cancer patients, using a population-based approach.Methods: This was a nationwide retrospective register study of all adult cancer deaths with documented information on PF in the last 24 h of life as reported to the Swedish Register of Palliative Care during a three-year period (n = 41,709). Prevalence and relief of symptoms during the last week of life as well as EOL care process quality indicators were assessed in relation to PF in those patients who had a documented decision to focus on EOL care (immediately dying, n = 23,112). Odds ratios were calculated, adjusting for place of death (hospital vs. non-hospital).Results: PF was administered to 30.9% of immediately dying patients in hospitals compared to 6.5% outside of hospitals. PF was associated with a higher likelihood for breathlessness and nausea. In patients screened for EOL symptoms with a validated instrument, PF was inversely associated with the likelihood of complete relief of breathlessness, respiratory secretions, anxiety, nausea and pain. Several palliative care quality indicators were inversely associated with PF, including EOL conversations and prescriptions of injectable drugs as needed. These associations were more pronounced in hospitals.Conclusions: Parenteral fluid therapy in the last 24 h of life was associated with inferior quality of the EOL care process and with increased symptom burden in imminently dying cancer patients.

Ämnesord och genrebeteckningar

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
MEDICIN OCH HÄLSOVETENSKAP Hälsovetenskap Omvårdnad hsv//swe
MEDICAL AND HEALTH SCIENCES Health Sciences Nursing hsv//eng
Cancer
End-of-life
Fluid therapy
Palliative care
Quality
Symptoms

Biuppslag (personer, institutioner, konferenser, titlar ...)

Mogensen, HannaDepartment of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (författare)
Tavelin, BjörnUmeå universitet,Institutionen för strålningsvetenskaper(Swepub:umu)bjta0001 (författare)
Eknert, JohannaUpper GI Unit, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden (författare)
Lundström, StaffanStockholms Sjukhem Foundation and Department of Oncology-Pathology, Stockholm, Sweden (författare)
Strang, PeterStockholms Sjukhem Foundation and Department of Oncology-Pathology, Stockholm, Sweden (författare)
Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Solna, Sweden; Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, SwedenDepartment of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (creator_code:org_t)

Sammanhörande titlar

Ingår i:BMC Palliative Care: BioMed Central (BMC)23:11472-684X

Internetlänk

Hitta via bibliotek

BMC Palliative Care (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

1 av 1
Föregående post
Nästa post
Till träfflistan

Hitta mer i SwePub

Av författaren/redakt...: Lindskog, Magnus; Mogensen, Hanna; Tavelin, Björn; Eknert, Johanna; Lundström, Staff ...; Strang, Peter

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Cancer och onkol ...

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Hälsovetenskap; och Omvårdnad

Artiklar i publikationen: BMC Palliative C ...

Av lärosätet: Umeå universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se